Larvol Delta - Efficacy-of-izokibep-a-novel-interleukin17A-inhibitor-in-moderate-to-severe-hidradenitis-suppurativa-A-patient-subgroup-analysis-from-a-randomised-doubleblind-placebocontrolled-multicentre-phase-3-study

izokibep (ABY-035) - Affibody

https://pagv3.virtual-meeting.org/eadv/eadvcongress2026/en-GB/pag/presentation/66950

Martina L. Porter

Jun 29, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next